Roche introduces NGS Avenio tumor tissue analysis kits for oncology research
Swiss multinational healthcare firm Roche has introduced three new next-generation sequencing (NGS) Avenio tumor tissue analysis kits for…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
16 Oct 18
Swiss multinational healthcare firm Roche has introduced three new next-generation sequencing (NGS) Avenio tumor tissue analysis kits for…
15 Oct 18
Spain-based healthcare firm Grifols has secured approval from the US Food & Drug Administration (FDA) for its ID…
10 Oct 18
Personalized medicine company Myriad Genetics has signed a commercialization plan with pharmaceutical giant Pfizer.
08 Oct 18
IQVIA and Genomics England have collaborated to develop a platform, which will connect clinical and de-identified genomics data…
08 Oct 18
Diagnostic information services provider Quest Diagnostics has entered into an agreement to divest its medical diagnostics business in…
08 Oct 18
Medical Engineering Technologies (MET), a UK-based company that has been providing laboratory services to the medical device and…
05 Oct 18
ivWatch, a provider of continuous monitoring devices for the early identification of intravenous (IV) infiltrations and extravasations, has…
03 Oct 18
ivWatch has received two patents granted by the European and Japanese Patent Offices expanding their intellectual property (IP)…
01 Oct 18
Adaptive Biotechnologies has secured de novo designation from the US Food and Drug Administration (FDA) for its clonoSEQ…
27 Sep 18
Abbott has secured CE mark for its High Sensitive Troponin-I blood test, which will help predict the chance…